HETEROGENEITY OF THE EFFECT OF COMBINED FRACTIONATED RADIOTHERAPY AND EGFR/HER2 TYROSINE KINASE INHIBITION

被引：0
作者：
Gurtner, K. [1 ,2 ]
Schuetze, C. [1 ,2 ]
Soica, F. [3 ]
Baumann, M. [1 ,2 ]
Krause, M. [1 ,2 ]
机构：
[1] Tech Univ, Dept Radiat Oncol, OncoRay Ctr Radiat Res Oncol, Fac Med, Dresden, Germany
[2] Tech Univ, Dept Radiat Oncol, OncoRay Ctr Radiat Res Oncol, Univ Hosp Carl Gustav Carus, Dresden, Germany
[3] Boehringer Ingelheim Austria, Vienna, Austria
来源：
RADIOTHERAPY AND ONCOLOGY | 2008年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
128
引用
收藏
页码：S42 / S43
页数：2
相关论文
共 50 条
[31]   HER2 Oncogenic Function Escapes EGFR Tyrosine Kinase Inhibitors via Activation of Alternative HER Receptors in Breast Cancer Cells [J].
Kong, Anthony ;
Calleja, Veronique ;
Leboucher, Pierre ;
Harris, Adrian ;
Parker, Peter J. ;
Larijani, Banafshe .
PLOS ONE, 2008, 3 (08)
[32]   HER2 therapy. Small molecule HER-2 tyrosine kinase inhibitors [J].
Neil Spector ;
Wenle Xia ;
Iman El-Hariry ;
Yossi Yarden ;
Sarah Bacus .
Breast Cancer Research, 9
[33]   The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer [J].
Hsu, Jennifer L. ;
Hung, Mien-Chie .
CANCER AND METASTASIS REVIEWS, 2016, 35 (04) :575-588
[34]   The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer [J].
Jennifer L. Hsu ;
Mien-Chie Hung .
Cancer and Metastasis Reviews, 2016, 35 :575-588
[35]   Comparison of Tyrosine Kinase Receptors HER2, EGFR and VEGFR Expression in Micropapillary Urothelial Carcinoma with Invasive Urothelial Carcinoma [J].
Li, J. ;
Yang, D. ;
Noble, L. ;
Resnick, M. ;
Amin, A. .
LABORATORY INVESTIGATION, 2013, 93 :229A-230A
[36]   Cell proliferation, nuclear ploidy, and EGFr and HER2/neu tyrosine kinase oncoproteins in infiltrating ductal breast carcinoma [J].
Val, JFF ;
Losada, J ;
Murua, MAAM ;
Sarría, R .
CANCER GENETICS AND CYTOGENETICS, 2002, 138 (01) :69-72
[37]   Efficacy of BIBW 2992, an irreversible dual EGFR/HER2 receptor tyrosine kinase inhibitor, in combination with cytotoxic agents [J].
Solca, F. ;
Baum, A. ;
Himmelsbach, F. ;
Amelsberg, A. ;
Adolf, G. .
EJC SUPPLEMENTS, 2006, 4 (12) :172-172
[38]   Optimization of Substituted 6-Salicyl-4-Anilinoquinazoline Derivatives as Dual EGFR/HER2 Tyrosine Kinase Inhibitors [J].
Li, Dong-Dong ;
Qin, Ya-Juan ;
Sun, Jian ;
Li, Jing-Ran ;
Fang, Fei ;
Du, Qian-Ru ;
Qian, Yong ;
Gong, Hai-Bin ;
Zhu, Hai-Liang .
PLOS ONE, 2013, 8 (08)
[39]   Comparison of tyrosine kinase receptors HER2, EGFR, and VEGFR expression in micropapillary urothelial carcinoma with invasive urothelial carcinoma [J].
Jianhong Li ;
Cynthia L. Jackson ;
Dongfang Yang ;
Lelia Noble ;
Michael Wheeler ;
Dolores MacKenzie ;
Temitope Adegun ;
Ali Amin .
Targeted Oncology, 2015, 10 :355-363
[40]   Comparison of Tyrosine Kinase Receptors HER2, EGFR and VEGFR Expression in Micropapillary Urothelial Carcinoma with Invasive Urothelial Carcinoma [J].
Li, J. ;
Yang, D. ;
Noble, L. ;
Resnick, M. ;
Amin, A. .
MODERN PATHOLOGY, 2013, 26 :229A-230A
12345